The effect of Tabex (cytisine) on success of attempts to stop smoking

Tabex（金雀花碱）对成功戒烟的影响

• 批准号: G0501300/1
• 负责人: Robert West
• 金额: $ 28.47万
• 依托单位: University College London
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2006
• 资助国家: 英国
• 起止时间: 2006 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=G0501300%2F1
• 关键词: effect; Tabex; cytisine; success; attempts

Promoting smoking cessation is probably the single most important goal in reducing cancer. There are several drugs that can help, and psychological support is also effective. There is an opportunity to evaluate a drug (Tabex) that has been in use in Eastern Europe for many years, is generic and cheap to manufacture ? so much so that it costs less than one fifth of current medications. This would be of considerable benefit to UK smokers, the NHS and perhaps more importantly to low income smokers overseas. The proposed rigorous trial would be conducted in Poland and would represent exceptional value for money.The findings will be taken forward through discussion with the MHRA and other relevant regulatory bodies to establish a basis for licensing. The results will also be dissemintated through appropriate press offices once a paper has been punlished in an appropriate peer review journal.

促进戒烟可能是减少癌症的唯一最重要的目标。有几种药物可以起到帮助作用，心理支持也很有效。有机会评估一种在东欧使用多年的药物(Tabex)，它是仿制药，生产成本低吗？如此之多，以至于它的成本不到目前药物的五分之一。这将对英国吸烟者、英国国民健康保险制度以及可能更重要的海外低收入吸烟者带来相当大的好处。拟议中的严格试验将在波兰进行，将是非常划算的。调查结果将通过与MHRA和其他相关监管机构的讨论来推进，以建立许可的基础。一旦一篇论文在适当的同行审查期刊上受到处罚，结果也将通过适当的新闻办公室传播。